79396591 - BIZENGRI

Information

  • Trademark
  • 79396591
  • Serial Number
    79396591
  • Filing Date
    April 18, 2024
    11 months ago
  • Transaction Date
    April 02, 2025
    4 days ago
  • Status Date
    April 01, 2025
    5 days ago
  • Location Date
    April 01, 2025
    5 days ago
  • Status Code
    680
  • Current Location
    TMO LAW OFFICE 127
    Employee Name
    BARANDAO,CHERISE D
  • Attorney Docket Number
    11137T00080U
    Attorney Name
    Jeffrey L. Clark
    Law Office Assigned Location Code
    N90
  • Owners
Mark Drawing Code
3
Mark Identification
BIZENGRI
Case File Statements
  • DM0000: The mark consists of the wording "BIZENGRI" in black with the first letter "I" appearing with a black base fading into green at the top and the design of a falcon with one wing in black and the other wing in green, with grey outlines on each side.
  • GS0051: Pharmaceutical and veterinary preparations prepared with multivalent proteins, including antibodies, used in industry and science, for use in the fields of immuno-oncology, and treating auto-immune disorders, hematological disorders and cancer
  • CC0000: The color(s) black, grey and green is/are claimed as a feature of the mark.
  • GS0011: Biochemical products used in industry and science, namely multivalent proteins, including antibodies used in industry and science, in the fields of immuno-oncology, auto-immune, hematological and other unmet medical needs.
  • GS0421: Services of biochemists; services of bacteriologic and biochemical laboratories, including advice in these aspects; drawing up of professional reports by scientists, engineers, analysts and laboratory assistants and technicians, for industry and government service, in particular in the field of multivalent proteins, including antibodies, in the fields of immuno-oncology, auto-immune, hematological and other unmet medical needs; scientific and industrial research in particular in the field of the aforementioned antibodies for use in immune-oncology, auto-immune, hematological and other unmet needs; research and development of new products for third parties, in particular in the field of antibodies for use in immune-oncology, auto-immune, hematological and other unmet needs
Case File Event Statements
  • 5/30/2024 - 10 months ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 6/1/2024 - 10 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/1/2024 - 10 months ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 10/31/2024 - 5 months ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/31/2024 - 5 months ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/7/2024 - 5 months ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 11/7/2024 - 5 months ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 11/1/2024 - 5 months ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 4/1/2025 - 5 days ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/1/2025 - 5 days ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/1/2025 - 5 days ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/1/2025 - 5 days ago
    15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 4/1/2025 - 5 days ago
    16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 4/1/2025 - 5 days ago
    14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 4/1/2025 - 5 days ago
    13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 4/1/2025 - 5 days ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/23/2024 - 4 months ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT